Kenneth A. Miller, PC — Los Gatos, California

Kenneth A. Miller, PC is a clinical research site located in Los Gatos, California, United States 95032.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Kenneth A. Miller, PC has participated in 1 clinical trials.

Therapeutic areas: Nonmelanoma Skin Cancer.

Sponsors: Xoft, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Los Gatos

Browse all research sites in California · View every site in Los Gatos

• Community Hospital of Los Gatos
• Stanford University
• Women's Cancer Center at Community Hospital of Los Gatos
• Women's Cancer Center - Community Hospital Los Gatos
• Research Site
• GSK Investigational Site
• Samaritan Center for Medical Research
• Pfizer Investigational Site
• Richard S. Cherlin, MD
• Local Institution
• Samaritan Center for Medical Research Medical Group
• Office of Dr. Richard S. Cherlin

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kenneth A. Miller, PC?

Kenneth A. Miller, PC has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kenneth A. Miller, PC conducted?

Kenneth A. Miller, PC has 1 clinical trials on record. Their work covers Nonmelanoma Skin Cancer.

Is Kenneth A. Miller, PC accredited by Crixeo Clinical Trials?

Kenneth A. Miller, PC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kenneth A. Miller, PC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.